Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial

NCT04653831 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT04653831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04653831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial
Lead sponsor
Soroka University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 8, 2020
Completion date
December 31, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid19